A recent study demonstrated that CAR-T cells transfected with siRNAs targeting PD-1 alone or in combination with siRNA targeting CTLA-4 produced more effector cytokines and showed a significant increase in cytotoxicity towards melanoma cells expressing PD-L1 as compared to control cells [123]. The gene discussed is CTLA4; the disease is melanoma.